RecruitingNot ApplicableNCT07088952

Triggering Ovulation at Follicle Size Smaller or Larger Than 17mm in a Modified Natural Cycle


Sponsor

Vida Recoletas Sevilla

Enrollment

572 participants

Start Date

Oct 22, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The rise in frozen embryo transfer (FET) cycles within assisted reproductive technology (ART) has sparked the need to refine endometrial preparation protocols. The switch from hormone replacement cycles (HRT) to natural cycles, poses scheduling challenges onto laboratories, doctors and patients. The modified natural cycle (mNC), offering more precision for scheduling, shows promise but lacks comprehensive data on the potential flexibility of triggering criteria that may allow to control timing in a wider range. This prospective randomized study seeks to address this knowledge gap by evaluating the non-inferiority of triggering ovulation in mNC with follicle diameters of 13-16.9mm compared to the conventional 17-22mm. The study aims to enhance the understanding of the impact of follicle size at ovulation in reproductive outcomes, optimize FET treatments providing a more flexible mNC protocol, and improve patient care in ART clinics.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years

Inclusion Criteria3

  • At least one expanded blastocyst (regardless of its quality)
  • Spontaneous menstrual cycles
  • Consent to undergo frozen embryo transfer in a modified natural cycle

Exclusion Criteria2

  • Abnormal uterine cavity
  • Fluid in endometrial cavity

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURETrigger at smaller folicular size

Trigger indicated at folicular diameter smaller than standard clinical practice, from 13mm to 16.9mm


Locations(1)

Vida Recoletas Sevilla

Seville, Sevilla, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07088952


Related Trials